Catalyst Pharmaceuticals Cash from Investing (TTM)

Catalyst Pharmaceuticals Inc (CPRX)

16.36

+0.24 (+1.49%) USD | NASDAQ | Mar 27, 12:17

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2022	9.209M
September 30, 2022	9.168M
June 30, 2022	9.232M
March 31, 2022	-4.11M
December 31, 2021	-11.02M
September 30, 2021	-10.98M
June 30, 2021	-20.92M
March 31, 2021	-16.92M
December 31, 2020	-5.011M
September 30, 2020	26.65M
June 30, 2020	41.71M
March 31, 2020	31.78M
December 31, 2019	37.22M
September 30, 2019	19.71M
June 30, 2019	22.24M
March 31, 2019	27.21M
December 31, 2018	-15.08M
September 30, 2018	-29.17M
June 30, 2018	-36.77M
March 31, 2018	-31.82M
December 31, 2017	-0.004M
September 30, 2017	0.5217M
June 30, 2017	2.751M
March 31, 2017	3.585M
December 31, 2016	3.553M

Date	Value
September 30, 2016	3.017M
June 30, 2016	0.7732M
March 31, 2016	-0.0288M
December 31, 2015	-0.0065M
September 30, 2015	-0.0659M
June 30, 2015	-0.0064M
March 31, 2015	-10.05M
December 31, 2014	-8.741M
September 30, 2014	-15.54M
June 30, 2014	-19.75M
March 31, 2014	-7.717M
December 31, 2013	-7.497M
September 30, 2013	-14.74M
June 30, 2013	-10.55M
March 31, 2013	-12.57M
December 31, 2012	-14.06M
September 30, 2012	1.995M
June 30, 2012	1.993M
March 31, 2012	-0.0086M
December 31, 2011	-0.0036M
September 30, 2011	-2.008M
June 30, 2011	-2.006M
March 31, 2011	-0.0029M
December 31, 2010
September 30, 2010

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-36.77M

Minimum

Jun 2018

41.71M

Maximum

Jun 2020

2.616M

Average

2.529M

Median

Cash from Investing (TTM) Benchmarks